In Depth 30 Apr 2025
The future of NSCLC treatment: what’s in store for the therapeutic space?
Here we delve into the different kinds of NSCLC therapies in the running to potentially address late-stage cancer that is often difficult to treat.
- Latest Posts
Best in Biotech 29 Apr 2025
Six biotech companies leading the charge in hemophilia treatment
Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi therapies.
News and Trends 28 Apr 2025
U.S. budget cuts: what is the impact on therapeutic research?
We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs and lawsuits.
Whitepapers 28 Apr 2025
Function-focused single-cell analysis to accelerate antibody discovery
Discover how early functional screening at the single-cell level transforms therapeutic development of your antibodies.
In Depth 25 Apr 2025
The past, present, and future of genome sequencing
Genome sequencing is the process of determining the complete DNA sequence of an organism’s genome, a step-by-step decoding of all the genetic instructions. In humans, that means reading around 3 billion base pairs to reveal everything from disease risk and drug response to ancestry and evolution. For many years, genome sequencing was largely limited to […]
Podcast 25 Apr 2025
AI in biotech today, and how it will impact the industry tomorrow
AI is driving innovation across industries, including biotech, but where is its influence felt most and what opportunities for future impact are emerging?
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 24 Apr 2025
21 UK biotech companies you should know about
Take a closer look at 21 of the top UK biotech companies, as the nation’s biotech scene is now one of the most vibrant in Europe.
In Depth 23 Apr 2025
The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval
Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in on FDA approval.
Expert Advice 22 Apr 2025
Tariffs and trade war: A guide for expanding biotech business internationally
Find out how you can mitigate the risks on your way to make your biotech company global amidst the tariffs and trade mayhem.
Best in Biotech 22 Apr 2025
Seven biotechs to watch in the hepatitis B space
Here we take a look at seven biotechs with clinical drug candidates on a quest to win regulatory approval to treat HBV.
In Depth 17 Apr 2025
Biomaterials in construction: meet the startups reinventing our buildings
We will explore the various biomaterials making a mark in the construction field and how biotechs could potentially transform a carbon-intensive industry.
Best in Biotech 16 Apr 2025
HIV innovation: Six companies developing new treatments in 2025
Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.
ADVERTISEMENT
